Table 1.
Characteristics of the BC patients included in this study (a) and normal control group with benign lesion disease or no lesion (b)
| Variables |
classes |
No. |
| Breast Cancer participants (a) | 70 | |
| Age | ≤ 40 | 17 |
| > 40 | 53 | |
| Histological grade | G1 and G2 | 42 |
| G3 | 11 | |
| Unknown | 17 | |
| Histological type | Insitu | 5 |
| Invasive | 57 | |
| Unknown | 7 | |
| Nuclear grade | G1 and G2 | 40 |
| G3 | 9 | |
| Unknown | 21 | |
| Molecular subtype | ER | P(43), N(4), U(23) |
| PR | P(39), N(8), U(23) | |
| HER2 | P(11), N(36), U(23) | |
| Ki67 factor | ≤ 20 | 26 |
| > 20 | 19 | |
| Unknown | 25 | |
| Control Group participants (b) | 60 | |
| Age | ≤ 40 | 25 |
| > 40 | 34 | |
| Unknown | 1 | |
| Normal type | No lesion | 21 |
| Benign lesion | 39 | |
G1: Grade1; G2: Grade2; G3: Grade3; ER: Oestrogen Receptor; PR: Progesterone Receptor; HER2: Human Epidermal Growth Factor Receptor; P: Positive; N: Negative; U: Unknown.